- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Natco Pharma Limited — Updates, 31-10-2025: Press Release
31-10-2025 | 09:02 am
31-10-2025 | 09:02 am
NATCO Pharma launched its Everolimus 1mg tablets, a generic version of Zortress®, in the U.S. market through its partner Breckenridge Pharmaceutical. This immunosuppressant for organ rejection prophylaxis expands NATCO's key U.S. offerings.
No comments yet. Be the first to comment!